2-(2-甲氧基苯基)-5-硝基-1H-苯并[d]咪唑 | 189162-32-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 中文名称: 2-(2-甲氧基苯基)-5-硝基-1H-苯并[d]咪唑
• 英文名称: 2-(2-methoxyphenyl)-5-nitro-1H-benzo[d]imidazole
• 英文别名: 2-(2-Methoxyphenyl)-6-nitro-1H-benzo[D]imidazole；2-(2-methoxyphenyl)-6-nitro-1H-benzimidazole
• CAS: 189162-32-1
• 化学式: C₁₄H₁₁N₃O₃
• 分子量: 269.26
• InChiKey: ALBGTLCEMRDPLW-UHFFFAOYSA-N

物化性质

• 沸点：
  519.8±56.0 °C(Predicted)
• 密度：
  1.372±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  83.7
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(2-甲氧基苯基)-5-硝基-1H-苯并[d]咪唑 在 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 、 异丙醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 10.0h， 生成 N-(2-(2-methoxyphenyl)-1H-benzo[d]imidazol-6-yl)quinazolin-4-amine
  参考文献：
  名称：

  Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2

  摘要：

  Both c-Met and VEGFR-2 are important targets for the treatment of cancers. In this study, a series of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinazolin-4-amine derivatives were designed and identified as dual c-Met and VEGFR-2 inhibitors. Among these compounds bearing quinazoline and benzimidazole fragments, compound 7j exhibited the most potent inhibitory activity against c-Met and VEGFR-2 with IC50 of 0.05μM and 0.02μM, respectively. It also showed the highest anticancer activity against the tested cancer cell lines with IC50 of 1.5μM against MCF-7 and 8.7μM against Hep-G2. Docking simulation supported the initial pharmacophoric hypothesis and suggested a common mode of interaction at the ATP-binding site of c-Met and VEGFR-2, which demonstrates that compound 7j is a potential agent for cancer therapy deserving further researching.

  DOI：

  10.1016/j.bmc.2014.07.008
• 作为产物：
  描述：

  邻甲氧基苯甲酸 、 4-硝基邻苯二胺 在 polyphosphoric acid (PPA) 作用下， 反应 5.0h， 以97%的产率得到2-(2-甲氧基苯基)-5-硝基-1H-苯并[d]咪唑
  参考文献：
  名称：

  的发现ñ - （2-苯基- 1 H ^ -苯并[ d ]咪唑-5-基）喹啉-4-胺衍生物是新颖的VEGFR-2激酶抑制剂

  摘要：

  抑制VEGF信号传导途径已成为治疗癌症的有价值的方法。在这项工作中，设计了一系列N-（2-苯基-1 H-苯并[ d ]咪唑-5-基）喹啉-4-胺衍生物并将其鉴定为VEGFR-2（KDR）激酶的有效抑制剂。合成了具有喹啉骨架和苯并咪唑部分的这些化合物，并评估了它们对VEGFR-2和两种人类癌细胞系的生物学活性。其中，化合物7s对VEGFR-2的抑制作用最强，IC 50为0.03μM，对受试癌细胞系的IC 50表现出最高的抗癌活性。针对MCF-7为1.2μM，针对Hep-G2为13.3μM。对接模拟支持最初的药效学假说，并提出了在VEGFR-2 ATP结合位点的共同相互作用方式，这表明化合物7s是潜在的癌症治疗药物，值得进一步研究。

  DOI：

  10.1016/j.ejmech.2014.07.071

文献信息

• Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
  申请人：Makovec Francesco

  公开号：US20050197331A1

  公开（公告）日：2005-09-08

  Heterocyclic amidines with anti-inflammatory and analgesic activity that inhibit nitrogen oxide production, of formula (I): in which: G 1 and G 2 are hydrogen, halogen, hydroxyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl, and an amidino substituent of formula Q, provided that, for each compound of formula (I), only one of the two substituents G 1 or G 2 is an amidino substituent of formula Q: and in which the substituents W, Y and X are combined to form 9- or 10-membered bicyclic heteroaromatic derivatives containing up to 2 hetero atoms in the same ring; and Z is an aryl or heteroaryl group, a linear or branched C 1 -C 6 alkyl or alkenyl chain, a C 1 -C 4 alkyl-aryl group or a C 1 -C 4 alkyl-heteroaryl group.

  含有抗炎和镇痛活性、抑制氮氧化物产生的杂环胺基化合物，化学式（I）如下：其中：G1和G2为氢、卤素、羟基、C1-C4烷氧基、C1-C4烷基和式为Q的胺基取代基，但对于化合物的每个化学式（I），G1或G2中仅有一个是式为Q的胺基取代基；其中取代基W、Y和X结合形成含有最多2个杂原子的同一环中的9-或10-成员双环杂芳衍生物；Z为芳基或杂芳基团、线性或支链状的C1-C6烷基或烯基链、C1-C4烷基-芳基团或C1-C4烷基-杂芳基团。
• Synthesis of new TCH/Ni‐based nanocomposite supported on SBA‐15 and its catalytic application for preparation of benzimidazole and perimidine derivatives
  作者：Mehdi Kalhor、Fahimeh Rezaee‐Baroonaghi、Akbar Dadras、Zohre Zarnegar

  DOI：10.1002/aoc.4784

  日期：2019.5

  microscopy, atomic absorption spectroscopy and N2 adsorption–desorption (Brunauer–Emmett–Teller) techniques. The catalytic performance of Ni/TCH@SBA‐15 (NNTS‐15) was determined for the synthesis of 2‐aryl‐substituted benzimidazoles and 2,3‐dihydroperimidines. The excellent yields within shorter reaction times, simplicity of catalytic methods, non‐toxicity and clean reactions, mild reaction conditions and easy

  通过用3-氯丙基三乙氧基硅烷（CPTES）和硫代碳酰肼（TCH）对二氧化硅纳米颗粒进行表面改性，然后与Ni（II）进行金属配体配位，合成了稳定的镍修饰SBA-15纳米复合材料（Ni / TCH @ SBA-15）。该有机金属纳米复合材料的结构通过傅立叶变换红外，场发射扫描电子显微镜，EDAX，透射电子显微镜，原子吸收光谱和N 2表征。吸附-解吸（Brunauer-Emmett-Teller）技术。测定了Ni / TCH @ SBA-15（NNTS-15）的催化性能，用于合成2-芳基取代的苯并咪唑和2,3-二氢过碘化吡啶。这些合成规程的重要优点是在较短的反应时间内获得优异的收率，简化的催化方法，无毒且反应干净，温和的反应条件和简便的后处理程序。此外，结合在SBA-15表面上的Ni（II）在催化反应条件下是稳定的，从而可有效回收和再利用。
• Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
  申请人：MAKOVEC Francesco

  公开号：US20100120802A1

  公开（公告）日：2010-05-13

  Heterocyclic amidines with anti-inflammatory and analgesic activity that inhibit nitrogen oxide production, of formula (I): in which: G 1 and G 2 are hydrogen, halogen, hydroxyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl, and an amidino substituent of formula Q, provided that, for each compound of formula (I), only one of the two substituents G 1 or G 2 is an amidino substituent of formula Q: and in which the substituents W, Y and X are combined to form 9- or 10-membered bicyclic heteroaromatic derivatives containing up to 2 hetero atoms in the same ring; and Z is an aryl or heteroaryl group, a linear or branched C 1 -C 6 alkyl or alkenyl chain, a C 1 -C 4 alkyl-aryl group or a C 1 -C 4 alkyl-heteroaryl group.

  具有抗炎和镇痛活性，能够抑制氮氧化物产生的杂环胺基化合物，化学式为（I）：其中：G1和G2是氢，卤素，羟基，C1-C4烷氧基，C1-C4烷基和公式Q的氨基甲基取代基，只有公式（I）中的两个取代基G1或G2中的一个是公式Q的氨基甲基取代基；其中取代基W，Y和X组合形成含有最多2个杂原子的9-或10成员双环杂芳基衍生物；Z是芳基或杂芳基基团，线性或分支的C1-C6烷基或烯基链，C1-C4烷基芳基基团或C1-C4烷基杂芳基基团。
• Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
  申请人：Rottapharm S.p.A.

  公开号：US07674809B2

  公开（公告）日：2010-03-09

  Heterocyclic amidines with anti-inflammatory and analgesic activity that inhibit nitrogen oxide production, of formula (I): in which: G1 and G2 are hydrogen, halogen, hydroxyl, C1-C4 alkoxy, C1-C4 alkyl, and an amidino substituent of formula Q, provided that, for each compound of formula (I), only one of the two substituents G1 or G2 is an amidino substituent of formula Q: and in which the substituents W, Y and X are combined to form 9- or 10-membered bicyclic heteroaromatic derivatives containing up to 2 hetero atoms in the same ring; and Z is an aryl or heteroaryl group, a linear or branched C1-C6 alkyl or alkenyl chain, a C1-C4 alkyl-aryl group or a C1-C4 alkyl-heteroaryl group.

  具有抗炎和镇痛活性，抑制氮氧化物产生的杂环胺基的化合物，化学式（I）：其中：G1和G2是氢，卤素，羟基，C1-C4烷氧基，C1-C4烷基和式Q的胺基取代基，条件是对于化合物（I）中的每个化合物，只有G1或G2中的一个取代基是式Q的胺基取代基；其中取代基W，Y和X组合形成含有最多2个杂原子的9-或10成员双环杂芳衍生物；并且Z是芳基或杂芳基团，线性或支链C1-C6烷基或烯基链，C1-C4烷基芳基基团或C1-C4烷基杂芳基基团。
• US7674809B2
  申请人：——

  公开号：US7674809B2

  公开（公告）日：2010-03-09